These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 34278979)
41. [Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]. El-Hage W; Hingray C; Lemogne C; Yrondi A; Brunault P; Bienvenu T; Etain B; Paquet C; Gohier B; Bennabi D; Birmes P; Sauvaget A; Fakra E; Prieto N; Bulteau S; Vidailhet P; Camus V; Leboyer M; Krebs MO; Aouizerate B Encephale; 2020 Jun; 46(3S):S73-S80. PubMed ID: 32370984 [TBL] [Abstract][Full Text] [Related]
42. cAIR: Implementation of peer response support for frontline health care workers facing the COVID-19 pandemic. Rubin EW; Rassman A Soc Work Health Care; 2021; 60(2):177-186. PubMed ID: 33761837 [No Abstract] [Full Text] [Related]
43. Women, opioid use and addiction. Goetz TG; Becker JB; Mazure CM FASEB J; 2021 Feb; 35(2):e21303. PubMed ID: 33433026 [TBL] [Abstract][Full Text] [Related]
44. What can we learn from COVID-19 to improve opioid treatment? Expert providers respond. Harris LM; Marsh JC; Khachikian T; Serrett V; Kong Y; Guerrero EG J Subst Use Addict Treat; 2023 Nov; 154():209157. PubMed ID: 37652210 [TBL] [Abstract][Full Text] [Related]
45. Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic. McCann Pineo M; Schwartz RM Psychol Trauma; 2020 Aug; 12(S1):S108-S110. PubMed ID: 32496102 [TBL] [Abstract][Full Text] [Related]
46. Telehealth Use during COVID-19: An Exploratory Study on Adaptations and Experiences of Providers. DeHart D; Iachini AL; Browne T; Reitmeier M; King LB Health Soc Work; 2024 Apr; 49(2):95-104. PubMed ID: 38459817 [TBL] [Abstract][Full Text] [Related]
47. Availability of Outpatient Telemental Health Services in the United States at the Outset of the COVID-19 Pandemic. Cantor JH; McBain RK; Kofner A; Stein BD; Yu H Med Care; 2021 Apr; 59(4):319-323. PubMed ID: 33480660 [TBL] [Abstract][Full Text] [Related]
48. Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications. Krsak M; Montague BT; Trowbridge P; Johnson SC; Binswanger IA J Infect Dis; 2020 Sep; 222(Suppl 5):S486-S493. PubMed ID: 32877543 [TBL] [Abstract][Full Text] [Related]
49. Essential Case Management Practices Amidst the Novel Coronavirus Disease 2019 (COVID-19) Crisis: Part 1: Tele-Case Management, Surge Capacity, Discharge Planning, and Transitions of Care. Tahan HM Prof Case Manag; 2020; 25(5):248-266. PubMed ID: 32452941 [TBL] [Abstract][Full Text] [Related]
50. Could Telehealth Improve Equity During the COVID-19 Pandemic? Sieck CJ; Rastetter M; McAlearney AS J Am Board Fam Med; 2021 Feb; 34(Suppl):S225-S228. PubMed ID: 33622843 [TBL] [Abstract][Full Text] [Related]
51. Social work leadership in a medical school: A coordinated, compassionate COVID-19 response. Jones BL; Phillips F; Shanor D; VanDiest H; Chen Q; Currin-McCulloch J; Franklin C; Sparks D; Corral C; Ortega J Soc Work Health Care; 2021; 60(1):49-61. PubMed ID: 33557718 [TBL] [Abstract][Full Text] [Related]
52. The Implementation of an Emergency Medicine Telehealth System During a Pandemic. Tresenriter M; Holdaway J; Killeen J; Chan T; Dameff C J Emerg Med; 2021 Apr; 60(4):548-553. PubMed ID: 33423835 [TBL] [Abstract][Full Text] [Related]
53. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Cochran G; Bruneau J; Cox N; Gordon AJ Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171 [TBL] [Abstract][Full Text] [Related]
54. Establishing a Telehealth Program in Primary Care for the Treatment of Opioid Use Disorder. Coulter KJ; Hintzsche MF J Dr Nurs Pract; 2020 Nov; 13(3):207-215. PubMed ID: 33334926 [TBL] [Abstract][Full Text] [Related]
55. Impact of COVID-19 on mental health and social service provision in Singapore: Learnings from a descriptive mixed-methods study for future resource planning. Goh ZZS; Chan LG; Lai JY; Lee J; Lee ES; Soon WSW; Toh A; Griva K Ann Acad Med Singap; 2023 May; 52(5):239-248. PubMed ID: 38904521 [TBL] [Abstract][Full Text] [Related]
57. Access to Medications for Opioid Use Disorder During COVID-19: Retrospective Study of Commercially Insured Patients from 2019-2022. Rajagopal S; Westra J; Raji MA; Wilkes D; Kuo YF Am J Prev Med; 2024 Apr; 66(4):635-644. PubMed ID: 37979624 [TBL] [Abstract][Full Text] [Related]
58. Implementation lessons from the transition to telehealth during COVID-19: a survey of clinicians and young people from youth mental health services. Nicholas J; Bell IH; Thompson A; Valentine L; Simsir P; Sheppard H; Adams S Psychiatry Res; 2021 May; 299():113848. PubMed ID: 33725578 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder. Velez FF; Luderer HF; Gerwien R; Parcher B; Mezzio D; Malone DC Postgrad Med; 2021 May; 133(4):421-427. PubMed ID: 33593201 [No Abstract] [Full Text] [Related]
60. Achieving Equity in Telehealth: "Centering at the Margins" in Access, Provision, and Reimbursement. Westby A; Nissly T; Gieseker R; Timmins K; Justesen K J Am Board Fam Med; 2021 Feb; 34(Suppl):S29-S32. PubMed ID: 33622814 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]